.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Colorcon
US Army
Baxter
QuintilesIMS
Daiichi Sankyo
Healthtrust
Argus Health
Covington
Harvard Business School

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050730

« Back to Dashboard

NDA 050730 describes ZITHROMAX, which is a drug marketed by Pfizer and is included in seven NDAs. It is available from fourteen suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the ZITHROMAX profile page.

The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the azithromycin profile page.

Summary for 050730

Tradename:1
Applicant:1
Ingredient:1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050730

Ingredient-typeMacrolides

Medical Subject Heading (MeSH) Categories for 050730

Suppliers and Packaging for NDA: 050730

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZITHROMAX azithromycin TABLET;ORAL 050730 NDA Pfizer Laboratories Div Pfizer Inc 0069-3080 0069-3080-30 30 TABLET, FILM COATED in 1 BOTTLE (0069-3080-30)
ZITHROMAX azithromycin TABLET;ORAL 050730 NDA Greenstone LLC 59762-3080 59762-3080-1 30 TABLET, FILM COATED in 1 BOTTLE (59762-3080-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 600MG BASE
Approval Date:Jun 12, 1996TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Jul 31, 2018Product Flag?Substance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Accenture
US Department of Justice
Chubb
Novartis
Fuji
Fish and Richardson
Farmers Insurance
Cantor Fitzgerald
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot